TC Biopharm (Holdings) Plc

TCBP · NASDAQ
Analyze with AI
6/30/2024
3/31/2024
12/31/2023
9/30/2023
Operating Activities
Net Income-$1,987-$3,322-$3,130-$3,130
Dep. & Amort.$121$127$190$190
Deferred Tax$0$0$0$0
Stock-Based Comp.$124$785$151$151
Change in WC-$991$102-$954-$954
Other Non-Cash$0-$101$1,747$1,747
Operating Cash Flow-$2,733-$2,409-$1,997-$1,997
Investing Activities
PP&E Inv.-$21$0$24$24
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$9-$6-$20-$20
Investing Cash Flow-$30-$6$4$4
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$20$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$2,786$913$2,261$2,261
Financing Cash Flow$2,786$933$2,261$2,261
Forex Effect$0$0$3$3
Net Chg. in Cash$23-$1,482$0$0
Supplemental Information
Beg. Cash$981$2,463$0$0
End Cash$1,004$981$0$0
Free Cash Flow-$2,763-$2,414-$1,972-$1,972